Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05391737
Other study ID # SIPE Cardiac function 001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 6, 2022
Est. completion date December 2026

Study information

Verified date January 2024
Source Dalarna County Council, Sweden
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Acute or chronic cardiac dysfunction could be a contributing factor to swimming-induced pulmonary edema (SIPE). Knowledge on cardiac function in SIPE is limited and recommendations for cardiac evaluation of patients with SIPE are lacking. The present study was designed to assess cardiac function in patients with SIPE and in asymptomatic swimmers.


Description:

Swimming induced pulmonary edema (SIPE) is an unusual condition occuring during swimming in cold open water. SIPE is characterized by acute onset of dyspnea and cough, excessive sputum and occasionally hemoptysis. Reversible myocardial dysfunction has been described in swimmers with SIPE and divers with immersion pulmonary edema (IPE). Cardiac dysfunction has also been discussed as a contributing factor triggering SIPE. However, prevalence, severity and prognosis of myocardial dysfunction in patients with SIPE is unknown. Official recommendations for cardiac evaluation of patients after an acute episode of SIPE is lacking. This case-control-study intends to assess cardiac function in patients with SIPE and in asymptomatic swimmers. We study a large cohort of approximately 12 000 swimmers during Vansbrosimningen, Sweden's biggest annual open water event, with a yearly incidence of SIPE of about 0,4%. Cardiac function is evaluated after swimming as well as at rest by echocardiography, 12-lead electrocardiogram and cardiac biomarkers (Troponin I, NT-pro-BNP).


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 2026
Est. primary completion date December 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: for patients: - respiratory symptoms during or after swimming at the Vansbrosimningen open water swimming event - diagnosis SIPE by signs of pulmonary edema on lung ultrasound - peripheral oxygen saturation =95% for controls: - completion of a swimming race of the Vansbrosimningen open water swimming event. - no respiratory symptoms during or after swimming - no signs of pulmonary edema on lung ultrasound - matched to patients with SIPE regarding sex and age Exclusion criteria: - declined consent - hemodynamic instability or decreased consciousness

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Echocardiography
Echocardiography after swimming (acute) and at rest (baseline)
Electrocardiogram (ECG)
Electrocardiogram (ECG) after swimming (acute) and at rest (baseline)
Cardiac biomarkers
high sensitive (hs)-Troponin I and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) after swimming (acute) and at rest (baseline)

Locations

Country Name City State
Sweden Center of Clinical Research Dalarna Falun

Sponsors (1)

Lead Sponsor Collaborator
Dalarna County Council, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acute Echocardiography Transthoracic echocardiography with parasternal, apical and subcostal views. Including measurement of ventricular wall size, left ventricular strain, ejection fraction according to the modified Simpson method, diastolic function (using tissue doppler, mitral flow and pulmonary vein flow), right ventricular tricuspid annular plane systolic excursion (TAPSE), pressure gradient over the tricuspid valve, assessment of valve dysfunction, size and respiratory variation of the inferior vena cava, assessment of pericardial fluid. within 4 hours after termination of swimming
Primary Acute Electrocardiogram (ECG) - Rytm analysis 12-lead electrocardiogram (ECG). Rytm analysis and frequency (beats per minute) within 4 hours after termination of swimming
Primary Acute Electrocardiogram (ECG) - Heart axis 12-lead electrocardiogram (ECG). Assessment of QRS-axis (degrees) within 4 hours after termination of swimming
Primary Acute Electrocardiogram (ECG) - Amplitudes and intervals 12-lead electrocardiogram (ECG). Duration of PQ-interval (ms), QRS-complex (ms), QT-interval (ms), QRS amplitude (mV) within 4 hours after termination of swimming
Primary Acute Electrocardiogram (ECG) - Signs of myocardial ischemia 12-lead electrocardiogram (ECG). ST-elevation, ST-depression, T-wave inversion, Q wave. within 4 hours after termination of swimming
Primary Acute cardiac biomarkers - Troponin I Venous samples. Measurement of hs-Troponin I (ng/L). 4-6 hours after termination of swimming
Primary Acute cardiac biomarkers - NT-pro-BNP Venous samples. Measurement of NT-pro-BNP (ng/L) 4-6 hours after termination of swimming
Secondary Baseline Echocardiography Transthoracic echocardiography with parasternal, apical and subcostal views. Examination at rest. Including measurement of ventricular wall size, left ventricular strain, ejection fraction according to the modified Simpson method, diastolic function (using tissue doppler, mitral flow and pulmonary vein flow), right ventricular tricuspid annular plane systolic excursion (TAPSE), pressure gradient over the tricuspid valve, assessment of valve dysfunction, size and respiratory variation of the inferior vena cava, assessment of pericardial fluid. within 12 months after swimming
Secondary Baseline Electrocardiogram (ECG) - Rytm analysis 12-lead Electrocardiogram (ECG). Examination at rest. Rytm analysis and frequency (beats per minute) within 12 months after swimming
Secondary Baseline Electrocardiogram (ECG)- Heart axis 12-lead Electrocardiogram (ECG). Examination at rest. Assessment of QRS-axis (degrees) within 12 months after swimming
Secondary Baseline Electrocardiogram (ECG) - Amplitudes and intervals 12-lead Electrocardiogram (ECG). Examination at rest. Duration of PQ-interval (ms), QRS-complex (ms), QT-interval (ms), QRS amplitude (mV) within 12 months after swimming
Secondary Baseline Electrocardiogram (ECG) - Signs of myocardial ischemia 12-lead Electrocardiogram (ECG). Examination at rest. ST-elevation, ST-depression, T-wave inversion, Q wave. within 12 months after swimming
Secondary Baseline cardiac biomarkers - Troponin I Venous samples. Measurement of hs-Troponin I (ng/L). Examination at rest within 12 months after swimming
Secondary Baseline cardiac biomarkers - NT-pro-BNP Venous samples. Measurement of NT-pro-BNP (ng/L). Examination at rest within 12 months after swimming
See also
  Status Clinical Trial Phase
Completed NCT05563701 - Evaluation of the LVivo Image Quality Scoring (IQS)
Completed NCT04908397 - Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension Phase 1
Terminated NCT03309358 - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Phase 1
Completed NCT03682354 - ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery N/A
Enrolling by invitation NCT03683186 - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Phase 3
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Recruiting NCT06004440 - Real World Registry for Use of the Ion Endoluminal System
Completed NCT04874948 - Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment Phase 1
Completed NCT02926768 - Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors Phase 1
Completed NCT01443845 - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Phase 4
Completed NCT00269256 - Stress, Environment, and Genetics in Urban Children With Asthma N/A
Terminated NCT00233207 - IC14 Antibodies to Treat Individuals With Acute Lung Injury Phase 2
Completed NCT00281216 - Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations N/A
Recruiting NCT00129350 - Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation Phase 1
Active, not recruiting NCT00115297 - Montelukast for Early Life Wheezing Phase 2/Phase 3
Completed NCT00094276 - Intervention for Improving Asthma Care for Minority Children in Head Start N/A
Completed NCT00091767 - Genetic Studies in Difficult to Treat Asthma: TENOR N/A
Completed NCT00083798 - Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland N/A
Completed NCT00069823 - Study of Acid Reflux in Asthma Phase 3
Completed NCT00089752 - Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea N/A